</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →
3002.13.00/Bulk Rituximab Monoclonal Antibody/Japan

Bulk Rituximab Monoclonal Antibody from Japan

Rituximab targets CD20 on B-cells for lymphoma and autoimmune treatment, a biotech-produced antibody. As an unmixed product not for retail, it fits HTS 3002.13.00 immunological products definition.

Duty Rate — Japan → United States

15%

Rate breakdown

9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Ensure BLA (Biologics License Application) reference; provide glycosylation profile analysis; declare bulk quantity to affirm non-retail status

Bulk Rituximab Monoclonal Antibody from Japan — Import Duty Rate | HTS 3002.13.00